It is characterized by a significantly higher frequency of TP53 variants (36%), especially bi-allelic/multi-hit TP53 alterations with relatively lower somatic mutational burden compared to other AML subtypes (31, 32). Here, TP53 is linked to acute myeloid leukemia.